Interpretation of the biological relevance of genotoxicity test results:: the importance of thresholds

被引:89
作者
Kirkland, DJ
Müller, L
机构
[1] Covance Labs, Harrogate HG3 1PY, North Yorkshire, England
[2] Bundesinst Arzneimittel & Med Prod, D-13353 Berlin, Germany
关键词
genotoxicity; biological relevance; thresholds; mechanisms;
D O I
10.1016/S1383-5718(99)00175-8
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Despite recent improvements in genotoxicity protocols, we have observed an increase in the occurrence of positive results, particularly in chromosomal aberration tests in vitro, yet very few of these are accompanied by positive responses in vivo. Thus, the positive results may not be biologically relevant either for rodents or humans in vivo, but how should we determine "biological relevance"? Chemicals that produce thresholded dose-responses may well not pose a genotoxic risk at low (relevant to human) exposures, but thresholds should not just be "seen"; there must be an explanation and understanding of the underlying mechanism. In addition to extremes of pH, ionic strength and osmolality, as have been identified previously, such mechanisms include indirect genotoxicity resulting from interaction with non-DNA targets, chemicals/metabolites which are inherently genotoxic but which, at low concentrations, are effectively conjugated and unable to form adducts, and production of specific metabolites under in vitro conditions that are not formed in rodents or humans in vivo. If such thresholded mechanisms can be identified at exposures which are well in excess of expected human exposure, then there may be a strong argument that the positive results are not biologically relevant. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:137 / 147
页数:11
相关论文
共 25 条
[11]  
*ICH, 1995, TOP S2A GEN GUID SPE
[12]   CHROMOSOMAL ABERRATION TESTS INVITRO - PROBLEMS WITH PROTOCOL DESIGN AND INTERPRETATION OF RESULTS [J].
KIRKLAND, DJ .
MUTAGENESIS, 1992, 7 (02) :95-106
[13]   Recommendations for spacing of test chemical concentrations in the mouse lymphoma tk mutation assay (MLA) [J].
Kirkland, DJ ;
Clements, J .
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 1998, 415 (1-2) :159-163
[14]   REPORT OF THE INTERNATIONAL WORKSHOP ON STANDARDIZATION OF GENOTOXICITY TEST PROCEDURES - REPORT OF THE IN-VITRO SUBGROUP [J].
KIRKLAND, DJ .
MUTATION RESEARCH, 1994, 312 (03) :211-215
[15]   Towards a validation of the micronucleus test [J].
KirschVolders, M .
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 1997, 392 (1-2) :1-4
[16]   Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay:: position of the GUM working group on the in vitro micronucleus test [J].
Miller, B ;
Pötter-Locher, F ;
Seelbach, A ;
Stopper, H ;
Utesch, D ;
Madle, S .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 1998, 410 (01) :81-116
[17]   Comparative evaluation of the in vitro micronucleus test and the in vitro chromosome aberration test: Industrial experience [J].
Miller, B ;
Albertini, S ;
Locher, F ;
Thybaud, V ;
Lorge, E .
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 1997, 392 (1-2) :45-59
[18]   LOW PH LEADS TO SISTER-CHROMATID EXCHANGES AND CHROMOSOMAL-ABERRATIONS, AND ITS CLASTOGENICITY IS S-DEPENDENT [J].
MORITA, T .
MUTATION RESEARCH-ENVIRONMENTAL MUTAGENESIS AND RELATED SUBJECTS, 1995, 334 (03) :301-308
[19]   THE QUALITY OF GENOTOXICITY TESTING OF DRUGS - EXPERIENCES OF A REGULATORY AGENCY WITH NEW AND OLD COMPOUNDS [J].
MULLER, L ;
KASPER, P ;
MADLE, S .
MUTAGENESIS, 1991, 6 (02) :143-149
[20]   Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment:: experience with pharmaceuticals [J].
Müller, L ;
Kasper, P .
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2000, 464 (01) :19-34